-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-08-16
The reference study used an enzyme-activity high-throughput screen to identify merbromin as a selective inhibitor of the SARS-CoV-2 main protease, 3CLpro. Kinetic, binding, and docking analyses supported a mixed-type inhibition mechanism and suggested more than one interaction site, providing a mechanistic starting point for antiviral inhibitor development.
-
WSP-5 for Live-Cell H2S Imaging
2026-08-15
WSP-5 converts hydrogen sulfide activity into a rapid fluorescent signal, enabling real-time measurements in cardiomyocyte stress models and donor-release experiments. Its fast turn-on response helps connect H2S deficiency with lipotoxicity and ER-stress phenotypes while preserving compatibility with live-cell workflows.
-
YAP–TEAD Super-Enhancers in Ectoderm Commitment
2026-08-14
Wang et al. show that YAP–TEAD activity establishes and regulates a super-enhancer network during early surface ectoderm commitment from pluripotent stem cells. By integrating three-dimensional genomic profiling with CRISPR-dCas9 perturbation and transcription-factor experiments, the study connects enhancer architecture to lineage progression and epithelial regeneration research.
-
Cy5-UTP: Mechanistic RNA Labeling for FISH
2026-08-14
Cy5-UTP enables direct, far-red visualization of RNA generated by in vitro transcription. This guide connects Cyanine 5-uridine triphosphate chemistry with FISH, RNA probe synthesis, and single-molecule studies of R-loop-associated replication stress.
-
Tranexamic Acid in Fibrinolysis Research
2026-08-13
Tranexamic Acid provides a water-compatible way to stabilize fibrin and interrogate plasmin-dependent biology without introducing DMSO or ethanol into the assay. This guide translates its mechanism into practical workflows for clot-stability studies, plasmin-induced neutrophil adherence assays, and exploratory wound-dressing research.
-
Dietary Arachidonic Acid and Humoral Immunity
2026-08-13
A 2025 study reports that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses and improve protection in mice, with supportive findings in human volunteers. Its central mechanistic contribution is linking lymph-node arachidonic acid metabolism to prostaglandin I2–cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.
-
Estradiol Workflows for Receptor–Autophagy Studies
2026-08-12
Build reproducible 17 beta-estradiol experiments that connect estrogen receptor signaling with transcription, autophagy, and tissue protection. This practical guide translates recent heart, aorta, and kidney findings into cell-based workflows, controls, and troubleshooting decisions.
-
Tubeimoside I as an ATP1A1-Targeting Senolytic
2026-08-12
A 2026 Phytomedicine study identifies tubeimoside I as a senolytic that preferentially eliminates senescent cells by targeting ATP1A1 and disrupting intracellular potassium homeostasis. Combined cellular, proteomic, and mouse-model evidence links this mechanism to mitochondrial apoptosis, reduced senescence-associated abnormalities, and improved motor function, while also highlighting the need for careful metabolic and toxicity controls.
-
Balsalazide Prodrug Evidence in Ulcerative Colitis
2026-08-11
Wiggins and Rajapakse evaluated balsalazide as a colon-activated 5-aminosalicylic acid prodrug, emphasizing bacterial azoreduction, remission induction, and tolerability in active ulcerative colitis. Their review suggests faster and more frequent symptomatic remission than mesalamine, while also clarifying the limits of translating clinical evidence into cell-based or animal inflammation research.
-
Tacrolimus (FK506): Reliable Immune Assays
2026-08-11
Learn how Tacrolimus (FK506), SKU B2143, can improve the interpretation of T-cell proliferation, cytokine, viability, and cytotoxicity assays. This scenario-driven guide covers mechanism, vehicle compatibility, dose selection, data interpretation, and practical vendor evaluation.
-
NF 449: A Precision Lens on Platelet P2X1
2026-08-10
NF 449 is a highly selective purinergic receptor antagonist that helps translational researchers separate P2X1-driven platelet signaling from broader P2-receptor biology. This thought-leadership analysis connects molecular selectivity, platelet assay design, thrombosis models, and antithrombotic agent research while defining the compound’s practical value beyond a conventional product description.
-
Phosphatase Inhibitor Cocktail 1 Guide
2026-08-09
Learn how Phosphatase Inhibitor Cocktail 1 (100X in DMSO), SKU K1012, supports phosphorylation-state preservation during lysate preparation for viability, proliferation, and cytotoxicity studies. This scenario-based guide covers compatibility, dilution, storage, interpretation, and practical vendor-selection criteria.
-
UTP Solution (100 mM) for Reliable RNA Assays
2026-08-08
This scenario-based guide explains how UTP Solution (100 mM), SKU K1048, can improve control of RNA synthesis and nucleotide-dependent workflows without being mistaken for a direct cell-viability reagent. It covers compatibility, preparation, storage, interpretation, and practical vendor-selection criteria for biomedical laboratories.
-
PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks
2026-08-07
A 2026 Poultry Science study developed PEI-LSP-RA-PLGA, a layered PLGA nanoparticle adjuvant designed to combine sustained delivery with intestinal immune targeting in chicks receiving an inactivated H9N2 vaccine. The formulation increased systemic IgG and intestinal IgA responses while implicating CCR9/CCR6 chemokine signaling, Toll-like and NOD-like receptor pathways, and the IgA-production network in its activity.
-
BMN 673 (Talazoparib): Spliceosome Regulation and PARP Inhib
2026-08-07
Explore how BMN 673 (Talazoparib) leverages spliceosome regulation to enhance PARP inhibitor sensitivity and precision in DNA repair-deficient cancer models. This cornerstone article uniquely integrates acetylation-dependent mechanisms and translational assay guidance.